Revolution Share Price
NASDAQ: RVMDW | Small Cap | Healthcare$6.49
-$0.11 (-1.67%) Last updated on 20 Nov, 2026 | 23:34 ISTRevolution Stock Performance
Revolution Share Price Chart
$0.00$0.00
L
H
Revolution Quarterly Profit & Loss
All figures in USD
Revolution Annual Profit & Loss
All figures in USD
Revolution Balance Sheet
All figures in USD Million
Revolution Cash Flow
Annually
All figures in USD Million
About Revolution
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Revolution Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $10.20 | $6.49 | -31.14% |
Oct 2026 | $8.65 | $9.43 | -22.36% |
Aug 2026 | $8.96 | $12.14 | +26.06% |
Jul 2026 | $9.24 | $9.63 | -3.22% |
Jun 2026 | $6.23 | $9.95 | +62.05% |
May 2026 | $4.72 | $6.14 | +23.79% |
Apr 2026 | $1.96 | $4.96 | +191.76% |
Mar 2026 | $1.92 | $1.70 | -21.30% |
Feb 2026 | $1.41 | $2.16 | +41.18% |
Jan 2026 | $0.78 | $1.53 | +61.05% |
Dec 2025 | $0.80 | $0.95 | +137.50% |
Nov 2025 | $0.40 | $0.40 | +0.50% |